Skip to main content
. 2023 Jan 10;24(2):1331. doi: 10.3390/ijms24021331
anti-β2GPI anti-β2-glycoprotein I
aCL Anticardiolipin antibodies
Anti-PS/PT anti-phosphatidylserine/prothrombin antibodies
APS Antiphospholipid syndrome
aPL Antiphospholipid antibodies
EC Endothelial cells
EPCR endothelial protein C receptor
HCQ hydroxychloroquine
ICH intracerebral haemorrhage
LA lupus anticoagulant
LDA low dose aspirin
LMWH Low molecular weight heparin (LMWH
NO Nitric oxide
eNOS Nitric oxide synthase
PAI-I Plasminogen activator inhibitor I
RA Rheumatoid arthritis
SLE systemic lupus erythematosus
TM Thrombomodulin
TF Tissue factor
TFPI Tissue factor pathway inhibitor
tPA Tissue-plasminogen activator
TLR4 Toll like receptor 4
UFH unfractionated heparin
USPSTF US Preventive Services Task Force
VKA vitamin K antagonists
VWF von Willebrand factor